291 related articles for article (PubMed ID: 31103317)
1. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
2. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
3. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
4. Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: response to oral acitretin.
Foxton G; Delaney T
Australas J Dermatol; 2011 Feb; 52(1):66-9. PubMed ID: 21332698
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic lichen planus-like reactions combined with infundibulocystic hyperplasia: pathway to neoplasia.
Kossard S; Thompson C; Duncan GM
Arch Dermatol; 2004 Oct; 140(10):1262-7. PubMed ID: 15492191
[TBL] [Abstract][Full Text] [Related]
6. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Seger EW; Tarantino IS; Neill BC; Wang T
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609455
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
8. Multiple Keratoacanthoma-like Syndromes: Case Report and Literature Review.
Karampinis E; Kostopoulou C; Toli O; Marinos L; Papadimitriou G; Roussaki Schulze AV; Zafiriou E
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541097
[TBL] [Abstract][Full Text] [Related]
9. When Surgery Won't Cut It: Successful Management of Eruptive Squamous Atypia With Combination Medical Therapy.
Yumeen S; Kahn BJ; Leonard A; Shah A; Qureshi AA; Saliba E
Cureus; 2023 Apr; 15(4):e37694. PubMed ID: 37206513
[TBL] [Abstract][Full Text] [Related]
10. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
11. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
12. Giant keratoacanthoma arising in hypertrophic lichen planus.
Giesecke LM; Reid CM; James CL; Huilgol SC
Australas J Dermatol; 2003 Nov; 44(4):267-9. PubMed ID: 14616493
[TBL] [Abstract][Full Text] [Related]
13. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
14. Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series.
Luu W; McRae MY
Australas J Dermatol; 2023 Nov; 64(4):556-559. PubMed ID: 37665127
[TBL] [Abstract][Full Text] [Related]
15. Generalized eruptive keratoacanthoma of Grzybowski: follow-up of the original description and 50-year retrospect.
Schwartz RA; Błaszczyk M; Jablonska S
Dermatology; 2002; 205(4):348-52. PubMed ID: 12444329
[TBL] [Abstract][Full Text] [Related]
16. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
Kossard S; Tan KB; Choy C
Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
[TBL] [Abstract][Full Text] [Related]
17. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments.
Manuskiatti W; Fitzpatrick RE
Arch Dermatol; 2002 Sep; 138(9):1149-55. PubMed ID: 12224975
[TBL] [Abstract][Full Text] [Related]
18. Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment.
Star P; Jackett LA; Cheung K; Wilmott JS; Ho G; Smith A; Long GV; Scolyer RA; Martin LK
Dermatol Ther; 2022 Jun; 35(6):e15472. PubMed ID: 35347815
[TBL] [Abstract][Full Text] [Related]
19. Eruptive Keratoacanthomas of the Upper Extremities Successfully Treated With Intralesional Corticosteroid After Multiple Treatment Failures.
Marka A; Hoyt BS; Linos K; Vidal NY
Dermatol Surg; 2020 Jun; 46(6):840-842. PubMed ID: 30964786
[No Abstract] [Full Text] [Related]
20. [Keratoacanthomas on recent tattoos: Two cases].
Kluger N; Douvin D; Dupuis-Fourdan F; Doumecq-Lacoste JM; Descamps V
Ann Dermatol Venereol; 2017 Dec; 144(12):776-783. PubMed ID: 29126557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
